1
|
Ueda D, Matsuda N, Takaba Y, Hirai N, Inoue M, Kameya T, Abe T, Tagaya N, Isogai Y, Kakihara Y, Bartels F, Christmann M, Shinada T, Yasuda K, Sato T. Analysis of vitamin D receptor binding affinities of enzymatically synthesized triterpenes including ambrein and unnatural onoceroids. Sci Rep 2024; 14:1419. [PMID: 38228813 PMCID: PMC10792010 DOI: 10.1038/s41598-024-52013-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Accepted: 01/12/2024] [Indexed: 01/18/2024] Open
Abstract
Onoceroids are a rare family of triterpenes. One representative onoceroid is ambrein, which is the main component of ambergris used as a traditional medicine. We have previously identified the onoceroid synthase, BmeTC, in Bacillus megaterium and succeeded in creating ambrein synthase by introducing mutations into BmeTC. Owing to the structural similarity of ambrein to vitamin D, a molecule with diverse biological activities, we hypothesized that some of the activities of ambergris may be induced by the binding of ambrein to the vitamin D receptor (VDR). We demonstrated the VDR binding ability of ambrein. By comparing the structure-activity relationships of triterpenes with both the VDR affinity and osteoclastic differentiation-promoting activity, we observed that the activity of ambrein was not induced via the VDR. Therefore, some of the activities of ambergris, but not all, can be attributed to its VDR interaction. Additionally, six unnatural onoceroids were synthesized using the BmeTC reactions, and these compounds exhibited higher VDR affinity than that of ambrein. Enzymatic syntheses of onoceroid libraries will be valuable in creating a variety of bioactive compounds beyond ambergris.
Collapse
Affiliation(s)
- Daijiro Ueda
- Graduate School of Science and Technology, Niigata University, Niigata, Japan
| | - Natsu Matsuda
- Graduate School of Science and Technology, Niigata University, Niigata, Japan
| | - Yuka Takaba
- Graduate School of Science and Technology, Niigata University, Niigata, Japan
| | - Nami Hirai
- Graduate School of Science and Technology, Niigata University, Niigata, Japan
| | - Mao Inoue
- Graduate School of Science and Technology, Niigata University, Niigata, Japan
| | - Taichi Kameya
- Graduate School of Science and Technology, Niigata University, Niigata, Japan
| | - Tohru Abe
- Graduate School of Science and Technology, Niigata University, Niigata, Japan
| | - Nao Tagaya
- Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Japan
| | - Yasuhiro Isogai
- Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Japan
| | - Yoshito Kakihara
- Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
| | - Florian Bartels
- Institute of Chemistry and Biochemistry, Freie Unversität Berlin, Berlin, Germany
| | - Mathias Christmann
- Institute of Chemistry and Biochemistry, Freie Unversität Berlin, Berlin, Germany
| | - Tetsuro Shinada
- Graduate School of Science, Osaka Metropolitan University, Osaka, Japan
| | - Kaori Yasuda
- Department of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, Imizu, Japan.
| | - Tsutomu Sato
- Graduate School of Science and Technology, Niigata University, Niigata, Japan.
| |
Collapse
|
2
|
Kutner A, Brown G, Kallay E. Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume I. Int J Mol Sci 2022; 23:ijms23126635. [PMID: 35743075 PMCID: PMC9224470 DOI: 10.3390/ijms23126635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Accepted: 06/07/2022] [Indexed: 02/05/2023] Open
Affiliation(s)
- Andrzej Kutner
- Department of Bioanalysis and Drug Analysis, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha, 02-097 Warsaw, Poland
- Correspondence:
| | - Geoffrey Brown
- School of Biomedical Sciences, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK;
| | - Enikö Kallay
- Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria;
| |
Collapse
|